CPT vs SBAC

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

CPT

39.2
AI Score
VS
SBAC Wins

SBAC

42.8
AI Score

Investment Advisor Scores

CPT

Nov 11, 2026
39score
Recommendation
AVOID NEW MONEY

SBAC

Nov 11, 2026
43score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CPT SBAC Winner
Forward P/E 62.5 20.8768 SBAC
PEG Ratio 9.1681 11.6081 CPT
Revenue Growth -2.3% -2.5% CPT
Earnings Growth 771.3% -0.5% CPT
Tradestie Score 39.2/100 42.8/100 SBAC
Profit Margin 71.1% 34.5% CPT
Beta 1.00 1.00 Tie
Implied Volatility N/A N/A Tie
AI Recommendation AVOID NEW MONEY HOLD Tie

Relative Price Performance (Last 90 Days)

CPT 1M: +1.1% · 3M: -10.3% SBAC 1M: +4.5% · 3M: +2.1%

Current Technical Phase

CPT

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -3.0%) with fading momentum, RSI 45

RSI (14): 45.5 · Price: $99.09

SBAC

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 58

RSI (14): 57.5 · Price: $190.03

Fundamentals Snapshot

Metric CPT SBAC
Market Cap — —
Forward P/E 215.4 24.0
Trailing P/E 9.3 20.7
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin 0.6% 0.7%
Operating Margin 0.2% 0.5%
EPS 10.70 9.26
Dividend Yield 0.04% 0.03%

Frequently Asked Questions

Based on our detailed analysis, SBAC is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.